Stock Markets April 27, 2026 08:13 AM

HawkEye 360 Begins IPO Roadshow, Seeks Up to $416 Million in Offering

Signals-intelligence firm files for New York Stock Exchange listing under ticker HAWK as underwriters size up demand

By Maya Rios
HawkEye 360 Begins IPO Roadshow, Seeks Up to $416 Million in Offering

HawkEye 360 launched the roadshow for its initial public offering, proposing to sell 16 million shares priced between $24.00 and $26.00 each and naming an overallotment option that could lift proceeds to about $416 million. The company has filed a registration statement with the Securities and Exchange Commission that has not yet become effective, and the stock would list on the New York Stock Exchange under the symbol HAWK if the offering proceeds.

Key Points

  • HawkEye 360 is offering 16 million common shares with a price range of $24.00 to $26.00 per share.
  • Underwriters have a 30-day option to buy up to 2.4 million additional shares; if exercised at the top of the range, the offering could raise about $416 million.
  • The company filed a registration statement with the SEC that is not yet effective; the shares are intended to list on the NYSE under the symbol HAWK. Sectors impacted include defense, national security, aerospace/space services, and capital markets.

HawkEye 360, a provider of space-based signals intelligence and analytics, has kicked off the roadshow for its planned initial public offering, the company said on April 27. The proposed offering would consist of 16 million shares of common stock with a proposed price range of $24.00 to $26.00 per share.

Under the terms disclosed, the underwriters hold a 30-day option to purchase up to an additional 2.4 million shares at the IPO price less the underwriting discount. If that overallotment option is fully exercised and the shares priced at the top of the indicated range, the transaction could generate roughly $416 million in gross proceeds.

HawkEye 360 plans to list its common stock on the New York Stock Exchange using the ticker symbol "HAWK." The company has submitted a registration statement with the Securities and Exchange Commission; however, that filing has not become effective. As disclosed, the securities cannot be sold until the registration statement is declared effective by the SEC.

The firms leading the underwriting effort are Goldman Sachs & Co. LLC and Morgan Stanley, which are serving as lead book-running managers. RBC Capital Markets, Jefferies and BofA Securities are named as additional book-running managers. Baird, Raymond James and William Blair are listed as bookrunners, with Drexel Hamilton acting as co-manager.

Headquartered in Herndon, Virginia, HawkEye 360 delivers signals intelligence services to defense, intelligence and national security customers. The company employs space-based collection and analytics to detect and geolocate radio-frequency emissions on a global scale.


Operational and market context

The offering structure includes a standard underwriter overallotment option and a defined price range that sets the maximum potential proceeds at the top of the indicated band if demand supports full exercise. The company’s reliance on the SEC registration process means transaction timing and ability to sell securities remain contingent on regulatory effectiveness.

What this means for stakeholders

  • If priced at the high end and with the overallotment fully exercised, the deal would raise about $416 million before expenses.
  • Execution of the offering depends on the SEC registration statement becoming effective; until then, securities cannot be sold.
  • Underwriters have typical options to increase the size of the deal, but those options are not guaranteed to be used.

Risks

  • The registration statement filed with the SEC has not become effective; until it is effective, the securities cannot be sold - this affects timing and certainty of the offering (capital markets, corporate finance).
  • The underwriters’ 30-day overallotment option to purchase up to an additional 2.4 million shares may not be exercised, which would reduce proceeds below the maximum stated amount - this impacts the company’s potential capital raise (capital markets).
  • Proceeds depend on placing shares within the stated $24.00 to $26.00 price range; pricing below the top of the range would yield less than the approximately $416 million maximum - relevant to the company's planned funding and investor demand (corporate finance).

More from Stock Markets

Australian Shares Slip as Healthcare, Financials and Gold Weigh on Index Apr 29, 2026 Fuchs posts Q1 results above forecasts, raises sales outlook for 2026 Apr 29, 2026 Huhtamaki Tops Q1 Expectations but Flags Rising Polymer Costs as Margin Risk Apr 29, 2026 Kambi Holds FY26 EBITA Target Despite €4m Colombia Tax Hit Apr 29, 2026 Pernod Ricard Calls Off Merger Negotiations With Brown-Forman Apr 29, 2026